期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
大学生生命教育问题探讨
1
作者 王丽 《佳木斯职业学院学报》 2014年第6期59-59,共1页
近几年,出现非常多的校园恶性事件,因此,社会各界越来越重视对于大学生的生命教育。
关键词 大学生 恶性实践 生命教育 理性认知
下载PDF
The clinical practice of ^(252)Cf neutron brachytherapy devices on malignant tumor in China 被引量:3
2
作者 Lei Xin Xu Xiaochun 《Engineering Sciences》 EI 2009年第4期51-60,共10页
The 252 Cf neutron brachytherapy devices were designed and manufactured after solving those problems: the shield difficulties for 252Cf neutron; the method and facilities for 252Cf neutron source deliver; the dose ca... The 252 Cf neutron brachytherapy devices were designed and manufactured after solving those problems: the shield difficulties for 252Cf neutron; the method and facilities for 252Cf neutron source deliver; the dose calculation and measurement for 252Cf neutron. From 1999 to 2009, more than twenty 252Cf neutron brachytherapy devices had been installed in China. The Chinese radiation oncologists implemented the 252 Cf neutron braehytherapy on more than 5 000 different kinds of cancer patients, including cervix cancer; endometrium cancer and achieved ideal results. For special presentation, they had breakthrough on radical treatment for low lying rectal adenocarcinoma with sphincter preservation and melanoma patients after the modification of 252Cf neutron intracavitary applicator and dose calibration. 展开更多
关键词 252Cf neutron 252Cf neutron brachytherapy device cervix cancer rectal adenocarcinoma MELANOMA APPLICATOR dose calibration
下载PDF
Fighting against hematological malignancy in China: from unique system to global impact 被引量:7
3
作者 LV Meng HUANG XiaoJun 《Science China(Life Sciences)》 SCIE CAS CSCD 2015年第12期1183-1190,共8页
During recent decades, substantial progress has been made in clinical strategies for treating hematological malignancies. Not only did China benefit from the global progression in the management of acute promyelocytic... During recent decades, substantial progress has been made in clinical strategies for treating hematological malignancies. Not only did China benefit from the global progression in the management of acute promyelocytic leukemia, risk-stratification-directed strategies for acute or chronic leukemia and haploidentical hematopoietic stem cell transplantation, the unique system developed by Chinese doctors has also become inspiration for refining global clinical practice. The multicenter trials and collaborations adhering to international standards might further strengthen the global impact and lead the way in specific fields of research worldwide. 展开更多
关键词 hematological malignancy acute promyelocytic leukemia acute myeloid leukemia chronic myeloid leukemia haploidentical hematopoietic stem cell transplantation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部